Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Revenue

Prelude Therapeutics had revenue of $4.58M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $16.72M, up 138.86% year-over-year. In the year 2025, Prelude Therapeutics had annual revenue of $12.14M with 73.43% growth.

• Revenue (ttm): $16.72M
• Revenue Growth: +138.86%
• P/S Ratio: 26.95
• Revenue / Employee: $211,646
• Employees: 79
• Market Cap: 450.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.14M	5.14M	73.43%
Dec 31, 2024	7.00M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error